Abstract
Purpose: To investigate the presence of SARS-CoV-2 RNA in tears of patients with moderate to severe coronavirus disease 2019 (COVID-19).
Design: Cross-sectional study.
Participants: Patients with laboratory-proven moderate to severe COVID-19.
Methods: Tears were collected within 48 hours of laboratory confirmation using 3 methods: conjunctival swab plus Schirmer’s test strips (group 1), conjunctival swab (group 2), and Schirmer’s test strips (group 3). Samples from both the eyes of each patient were transported in a single viral transport media for real-time RT-PCR. Detailed demographic profiles, systemic symptoms, comorbidities, and ocular manifestations were noted.
Main outcome measures: Viral load of a sample was determined using cycle threshold (Ct) value of E gene. A specimen was considered to show positive results if the amplification curve for the E gene crossed the threshold line within 35 cycles and if it showed positive results on an RNA-dependent RNA polymerase or open reading frame 1b gene assay.
Results: Of the 78 patients enrolled in the study, samples from 3 patients were found to be inadequate for analysis. Thirty-six patients (48%) had moderate disease, whereas 39 patients (52%) had severe disease, with no ocular involvement in any patient. In the 75 patients, RT-PCR analysis of tears showed positive results in 18 patients (24%), and 29 of 225 samples (12.9%) showed positive results. Positive results were found in 11 (14.7%), 11 (14.7%), and 7 (9.3%) patients in groups 1, 2, and 3, respectively (P = 0.3105). Mean Ct values in groups 1, 2, and 3 were 28.36 ± 6.15, 29.00 ± 5.58, and 27.86 ± 6.46 (P = 0.92), respectively. Five patients showed positive RT-PCR results by all 3 methods (mean Ct value, 25.24 ± 6.33), and 12 patients showed positive results by any of the 3 methods (mean Ct value, 32.16 ± 1.94), the difference in Ct values being statistically significant (P = 0.029). The median value of symptomatology in patients with positive RT-PCR results from tears was 5 days (range, 4-9 days).
Conclusions: SARS-CoV-2 RNA was detected in tears of 24% of patients with laboratory-proven moderate to severe COVID-19. Conjunctival swab remains the gold standard of tear collection for RT-PCR assay. A significantly higher possibility of viral transmission exists through tears in patients with moderate to severe COVID-19.
Keywords: COVID-19; Conjunctival swab; Nasopharyngeal swab; Reverse-transcriptase polymerase chain reaction; SARS-CoV-2.
【저자키워드】 COVID-19, SARS-CoV-2, Nasopharyngeal swab, reverse-transcriptase polymerase chain reaction, Conjunctival swab, 【초록키워드】 coronavirus disease, SARS-CoV-2, Coronavirus disease 2019, severe COVID-19, Comorbidities, outcome, Nasopharyngeal swab, polymerase chain reaction, cross-sectional study, Symptomatology, Viral load, cycle threshold, nasopharyngeal, reverse-transcriptase polymerase chain reaction, Patient, Ct value, gold, RNA-dependent RNA polymerase, Viral transmission, SARS-CoV-2 RNA, viral transport media, Swab, eye, real-time RT-PCR, group, threshold, moderate, RT-PCR assay, patients, positive RT-PCR, Open reading frame, Analysis, severe disease, manifestation, Ct values, 48 hours, Chain Reaction, moderate to severe, Frame, moderate disease, severe coronavirus disease, gold standard, E gene, positive result, specimen, profiles, systemic symptoms, RT-PCR analysis, positive, median value, laboratory confirmation, conjunctival, tears, ocular, Tear, amplification curve, polymerase chain, enrolled, collected, Sample, was determined, significantly higher, statistically significant, transported, 48 hour, patients with moderate, 【제목키워드】 SARS-CoV-2, Tear,